Clinical Pharmacokinetics and Pharmacodynamics of Evolocumab, a PCSK9 Inhibitor. [electronic resource]
Producer: 20191004Description: 769-779 p. digitalISSN:- 1179-1926
- Animals
- Antibodies, Monoclonal -- chemistry
- Antibodies, Monoclonal, Humanized
- Anticholesteremic Agents -- chemistry
- Cardiovascular Diseases -- blood
- Clinical Trials as Topic -- methods
- Enzyme Inhibitors -- chemistry
- Humans
- Hyperlipidemias -- blood
- PCSK9 Inhibitors
- Proprotein Convertase 9 -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.